Chemotherapy Before Radiotherapy in Cervical Cancer
Author Information
Author(s): R.P. Symonds, R.A. Burnett, T. Habeshawl, S.B. Kaye, M.P. Sneel, E.R. Watson
Primary Institution: Beatson Oncology Centre, and Department of Pathology, Western Infirmary, Glasgow
Hypothesis
Does response to chemotherapy improve survival in advanced cervical cancer patients receiving subsequent radiotherapy?
Conclusion
Patients who responded to chemotherapy had significantly better survival rates after radiotherapy compared to non-responders.
Supporting Evidence
- 53% of patients had an objective response to chemotherapy.
- 71% of chemotherapy responders survived 24 months compared to 37% of non-responders.
- All chemotherapy responders had a complete response to radiotherapy.
Takeaway
Giving chemotherapy before radiation helps some cervical cancer patients live longer and have better treatment results.
Methodology
Patients received cisplatin, vincristine, and bleomycin chemotherapy before radiotherapy, with follow-up assessments for response and survival.
Potential Biases
Potential biases in patient selection and response assessment due to retrospective review of biopsy material.
Limitations
The study had a small sample size and was a pilot study, limiting the generalizability of the results.
Participant Demographics
Mean age of participants was 49 years, with 40 in stage III and 15 in stage IVa, all having squamous carcinomas.
Statistical Information
P-Value
0.014
Confidence Interval
95% CI 15-81%
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website